Oct 9 |
Illumina introduces new DNA sequencing instruments, but Street unimpressed
|
Oct 9 |
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers
|
Oct 8 |
Here's Why Illumina (ILMN) is a Strong Momentum Stock
|
Oct 7 |
Illumina to Announce Third Quarter 2024 Financial Results on Monday, November 4, 2024
|
Oct 7 |
Revisiting Illumina
|
Oct 3 |
Charles Dadswell to step down as General Counsel, Illumina initiates search for successor
|
Oct 2 |
Illumina, Inc. (ILMN): A Bull Case Theory
|
Sep 30 |
Shareholders in Illumina (NASDAQ:ILMN) are in the red if they invested three years ago
|
Sep 20 |
VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
|
Sep 20 |
Longboard Stock Soars on FDA Designations for Epilepsy Drug
|